Physician

Mark E Hinkson, D.O.

According to 2025 Medicare claims, Mark Hinkson, D.O. (NPI: 1538257431) practices dermatology in the Idaho Falls, ID market, with the plurality of this provider's patient population coming from Bonneville, ID. This provider's primary affiliated billing organization is MARK E HINKSON DERMATOLOGY PA (NPI: 1437210994; TIN: 20-1110487) and primary practice location at 83404-7430. Hinkson is affiliated with the MountainStar Care Partners ACO (ACO ID: A5181) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Hinkson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 458 traditional Medicare patients, billed 13,586 HCPCS/CPT codes, and received $526,731 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 543 prescription claims across 231 beneficiaries totaling $112,931 in drug costs, led by Fluorouracil (Fluorouracil). Open Payments data shows 2 records totaling $38. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $125,296 to $526,731. Similarly, Part D prescription costs have moved sharply higher in recent years, from $26,237 to $112,931. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	477	3,399	$125,296
2016	506	3,421	$127,056
2017	518	3,822	$132,448
2018	490	6,903	$141,523
2019	520	9,291	$178,078
2020	456	7,188	$132,616
2021	464	9,054	$150,341
2022	411	6,590	$123,219
2023	414	13,532	$562,903
2024	458	13,586	$526,731

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	167	422	$26,237
2016	181	444	$27,832
2017	161	363	$20,027
2018	190	500	$29,024
2019	193	520	$25,663
2020	191	488	$23,311
2021	189	477	$22,203
2022	195	508	$118,466
2023	200	452	$100,281
2024	231	543	$112,931

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	94	111	$66
11102	Biopsy of related skin growth, first growth	211	250	$54
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	387	640	$50
17000	Destruction of precancer skin growth, 1 growth	262	404	$30
17003	Destruction of precancer skin growth, 2-14 growths	216	1,394	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Fluorouracil	Fluorouracil	16	462	$2,048
Clindamycin Phosphate	Clindamycin Phosphate	23	630	$1,331
Fluocinonide	Fluocinonide	36	1,192	$1,228
Ketoconazole	Ketoconazole	77	2,298	$1,042
Triamcinolone Acetonide	Triamcinolone Acetonide	60	1,919	$862

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$38	UCB, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark E. Hinkson, D.O.?

Tedicare shows public-source Medicare data for Mark E. Hinkson, D.O. (NPI 1538257431), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark E. Hinkson, D.O. have ACO affiliation data?

Mark E. Hinkson, D.O. is shown with ACO affiliation data for MountainStar Care Partners ACO (MSSP, ACO ID A5181) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Mark E. Hinkson, D.O.?

Mark E. Hinkson, D.O. is linked to MARK E HINKSON DERMATOLOGY PA (billing NPI 1437210994) in the available physician profile data.

Does Mark E. Hinkson, D.O. have Open Payments data?

Mark E. Hinkson, D.O. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.